USA Financial Formulas Acquires New Position in iShares U.S. Healthcare ETF $IYH

USA Financial Formulas acquired a new stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 39,109 shares of the company’s stock, valued at approximately $2,546,000. iShares U.S. Healthcare ETF accounts for approximately 0.5% of USA Financial Formulas’ investment portfolio, making the stock its 13th biggest position.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. acquired a new stake in shares of iShares U.S. Healthcare ETF in the 3rd quarter valued at approximately $36,000. First Horizon Corp purchased a new stake in shares of iShares U.S. Healthcare ETF in the third quarter valued at approximately $51,000. Newbridge Financial Services Group Inc. acquired a new position in iShares U.S. Healthcare ETF during the second quarter worth $56,000. Davis Capital Management acquired a new position in iShares U.S. Healthcare ETF during the third quarter worth $59,000. Finally, Triumph Capital Management purchased a new position in iShares U.S. Healthcare ETF in the third quarter worth $59,000.

iShares U.S. Healthcare ETF Stock Performance

NYSEARCA:IYH opened at $60.06 on Friday. iShares U.S. Healthcare ETF has a 1 year low of $53.35 and a 1 year high of $67.63. The stock has a fifty day moving average price of $64.46 and a two-hundred day moving average price of $63.30. The stock has a market capitalization of $3.22 billion, a price-to-earnings ratio of 21.05 and a beta of 0.65.

About iShares U.S. Healthcare ETF

iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology.